Merck Highlights New Data for Evobrutinib…
…First BTKi to Demonstrate Sustained Clinical Benefit for People with RMS through Three and a Half Years of Treatment This data suggests the long-term positive […]
clinical
Immune Biosolutions reports that its lead immunotherapy product IBIO123 neutralizes 100% of the SARS-CoV-2 variants of concern (VOCs), including Omicron
Immune Biosolutions Inc., a clinical-stage company, is pleased to announce that its leading biological drug candidate maintains a potent activity in neutralization assays. Recent results […]
Alligator Bioscience Announces Trial Update and Early Readout for ATOR-1017 Confirming Biomarker, Safety & Tolerability Data
Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the on-going clinical Phase I trial with the 4-1BB (CD137) drug candidate ATOR-1017, which is […]
Biocytogen/Eucure Biopharma Announce the Completion of First Patient Dosing for Phase I Clinical Trial of YH004 (Anti-4-1BB Monoclonal Antibody) in Australia
Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase I clinical trial of YH004 (anti-4-1BB monoclonal antibody, mAb) (No. […]
First Clinical Trial Authorised in Germany for a Peptide Vaccine against COVID-19
On 25 November 2020, the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, authorised the first phase 1 clinical trial of a peptide vaccine against COVID-19 […]
New Clinical Trial for a COVID-19 Vaccine Authorised in Germany
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines has authorised another Phase-1 clinical trial of a vaccine against COVID-19 in Germany. The new vaccine candidate […]
Paul-Ehrlich-Institut – Another Clinical Trial of a COVID-19 Vaccine authorised in Germany
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has authorised another clinical trial of a vaccine against COVID-19 in Germany. The intensive preliminary scientific advice […]
Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia
Roche is also close to completing enrolment of a global randomised, double-blind, placebo-controlled phase III clinical trial of Actemra®/RoActemra® (tocilizumab) in hospitalised patients with severe […]
Paul-Ehrlich Institut : First Clinical Trial of a COVID-19 Vaccine Authorised in Germany
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has authorised the first clinical trial of a vaccine against COVID-19 in Germany. Spike-Protein SARS-CoV-2 (Source: Viaframe/Corbis/GettyImages) […]
Second webinar organized on 23 April by the “COVID-19 Clinical Management Support System” on “inherited arrhythmia syndromes and COVID-19”
Two experts from the ERN GUARD-HEART and the Hospital Clínic of Barcelona in Spain will hold the seminar, which will take place on 23 April […]
EU Commission launches “COVID-19 Clinical Management Support System”
On 24 March, the European Commission launched the “COVID-19 Clinical Management Support System” with the aim to support clinicians in hospitals that are currently facing […]
Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic
The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA) have published new recommendations for sponsors on how to manage […]